Skip to main content

On This Page

← AI Financial News

Urban Outfitters – 2025-11-28 - Increase Confidence 8/10

2 min read $URBN
Share

These articles are AI-generated summaries. Please check the original sources for full details.

URBNUrban Outfitters, Inc.
$77.56-0.45 (-0.58%)
$78$69$60Aug 27Oct 13Nov 26
52W High: $78.0152W Low: $59.57Volume: 10.07M
NasdaqGS
Prediction (12/12/2025):High: $80.71Low: $41.89Ref Price: $77.56
This chart shows historical data as of November 26, 2025. Not updated in real-time.

URBN – Increase in Days/Weeks

Free cash flow surged to $320.3M (TTM) despite negative operating cash flow flag, while Q3 net sales jumped 12.3% to $1.53B. Just three days after reporting record net income of $116.4M, UBS raised its price target to $80, signaling strong institutional confidence.

Why This Matters

Urban Outfitters is demonstrating resilient brand momentum, particularly in its high-growth Free People and Anthropologie segments, which are offsetting softness in the core Urban Outfitters brand. The 48.7% surge in subscription sales (Nuuly) and 8.0% comparable retail sales growth reflect effective digital and omnichannel execution, while aggressive share repurchases ($152M YTD) and store expansion (41 new locations) signal management’s confidence in sustained demand—making the current price a potential springboard toward its 52-week high.

Key Insights

  • Record Q3 Results: Net income of $116.4M and EPS of $1.28 beat prior expectations, with total sales up 12.3% YoY to $1.53B
  • News Impact: UBS raised price target to $80 (from $70) on Nov 28, 2025, citing strong segment performance and margin resilience
  • Risk/Offset: Inventory up 5.9% YoY raises potential overstock concerns if holiday demand underperforms

Practical Implications

  • Bull Case: Continued momentum in subscription and wholesale segments + holiday spending tailwinds → breakout above $80.71 52-week high
  • Bear Case: Rising inventory levels and mixed brand performance (struggling Urban Outfitters brand) could trigger profit-taking near resistance
  • Confidence: 8/10 – Strong earnings, institutional endorsement, and buyback activity outweigh near-term risks

Prediction: increase

Reference:

Continue reading

Next article

Vera Therapeutics (VERA) – 2025-11-28 - Increase Confidence 6/10

Previous Analysis for $URBN

Related Content